Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos One|May 2, 2015
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsisElisa Damiani, Erica Adrario, Michele Maria Luchetti, et al.
Frontiers in Medicine|October 11, 2021
An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA StudyAlen Zabotti, Michele Maria Luchetti, Carlo Francesco Selmi, et al.
European Journal of Internal Medicine|May 4, 2019
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Devis Benfaremo, Emanuele Bendia, et al.
The Journal of Rheumatology|February 9, 2018
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel DiseaseMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
The Journal of Rheumatology|July 17, 2020
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel DiseasesDevis Benfaremo, Michele Maria Luchetti, Marco Di Carlo, et al.
Rheumatology (Oxford, England)|May 23, 2020
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|May 19, 2025
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT StudyValentino Paci, Fabian Proft, Alice Agostinelli, et al.
Arthritis Research & Therapy|October 11, 2023
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyMichele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, et al.
RMD Open|March 24, 2026
Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the 'AIRE' multicentre studyValentino Paci, Alen Zabotti, Alessandro Fontanarosa, et al.
European Journal of Clinical Investigation|November 16, 2022
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trialAlessia Ferrarini, Angelo Vacca, Antonio Giovanni Solimando, et al.
Pageof 4